InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Semigran Marc, Directeur Médical. Director active across 1 companies, notably Renovacor, Inc.. Aggregated, 2 reports have been recorded. The latest transaction was disclosed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
017,425 shares0
Common Stock
SEC:0000899243-22-003302·
017,425 shares0
Common Stock
SEC:0000899243-22-003302:0·
2 of 2 declarations
About Semigran Marc
Marc Semigran is the Chief Medical Officer of Renovacor, Inc. In this role, he oversees the medical and clinical initiatives of the company, which focuses on developing innovative therapies. With a strong background in the medical field, he plays a crucial role in the research and development strategy of Renovacor, Inc.
